St. Jude Medical (STJ) Gains FDA Clearance of EnSite Precision Cardiac Mapping System

December 15, 2016 8:02 AM EST Send to a Friend
St. Jude Medical, Inc. (NYSE: STJ) announced FDA clearance of its EnSite Precision™ cardiac mapping system and Advisor™ FL Circular ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to Premium below (Free Trial) LEARN MORE

Member Login